Reason: NASH cirrhosis, CT in May 2016 showed ill-defined arterial enhancement in the right hepatic lobe, please evaluate further - needs MAC due to severe claustrophobia History: NASH cirrhosis ABDOMEN:LIVER, BILIARY TRACT: There is mild diffuse loss of signal on out of phase images suggestive of hepatic steatosis.No suspicious focal hepatic lesions are identified. Specifically, in the area of increased enhancement in the hepatic dome (segments 4A and 8) described on comparison CT, there is no corresponding T1, T2, or DWI signal abnormality. There is perhaps minimally increased ill-defined enhancement on more delayed images in this area, but this is equivocal.The hepatic vasculature appears patent.Status post cholecystectomy. Mild intra and extrahepatic biliary ductal prominence appearing similar to comparison CT. The common bile duct measures up to 9 mm without evidence of obstructing stricture or stone.SPLEEN: The spleen is upper normal in size without focal lesions. Normal variant splenule.PANCREAS: The pancreas demonstrates normal parenchymal signal intensity and enhancement. The pancreatic duct is nondilated.ADRENAL GLANDS: No significant abnormality noted.KIDNEYS, URETERS: No significant abnormality noted.RETROPERITONEUM, LYMPH NODES: Few nonspecific mildly prominent upper abdominal lymph nodes. For example, right pericaval lymph node measures 1.2 x 1.5 cm. Mildly prominent cardiophrenic lymph node has a normal fatty hilum and appears similar to recent CT.BOWEL, MESENTERY: No significant abnormality noted.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.
1.Hepatic steatosis.2.No suspicious focal hepatic lesions identified. 